BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  IntegraGen, Inc. Collaborating With New EPOC Study Investigators To Validate Metastatic Colorectal Cancer Biomarker

  January 14, 2014

   · 

  1 min read
• Lone Star Bio

  Kinetic Concepts, Inc. Negative Pressure Wound Therapy With Instillation Supplement Published In International Wound Journal

  January 14, 2014

   · 

  1 min read
• Drug Development

  CytRx Corporation Doses First Patient In Phase 2 Clinical Trial With Aldoxorubicin For The Treatment Of Unresectable Glioblastoma Multiforme (Brain Cancer)

  January 14, 2014

   · 

  1 min read
• BioMidwest

  Regenstrief And Indiana University Review Finds Lack Of Delirium Screening In The Emergency Department

  January 14, 2014

   · 

  3 min read
• Policy

  The Journal Of Medical Device Regulation Has A New Look

  January 14, 2014

   · 

  1 min read
• AEterna Zentaris Announces Closing Of $13.2 Million Public Offering Of Common Shares And Warrants

  January 14, 2014

   · 

  3 min read
• Genetown

  RXi Pharmaceuticals Receives US Notice Of Allowance For A Key Patent Relating To Its Self-Delivering Technology With Sd-Rxrnas Targeting CTGF, Including RXI-109, For The Treatment Of Fibrotic Disorders

  January 14, 2014

   · 

  4 min read
• Drug Development

  Nektar Therapeutics (CA) Release: First Subjects Dosed In Phase 1 Clinical Study Of NKTR-171, A New Peripherally-Restricted Sodium Channel Blocker To Treat Neuropathic Pain

  January 14, 2014

   · 

  8 min read
• Drug Development

  Nektar Therapeutics (CA) Release: Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis For BEACON Pivotal Phase 3 Clinical Study In Patients With Metastatic Breast Cancer

  January 14, 2014

   · 

  10 min read
• Pharm Country

  Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Study For Second Opioid Abuse Deterrent Product

  January 14, 2014

   · 

  1 min read